Gewei Gene
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Gewei Gene - overview
Established
2018
Location
Guangzhou, Guangdong, China
Primary Industry
Biotechnology
About
Based in Guangzhou, China and established in 2018, Gewei Gene is a medical technology that focuses on providing cancer detection services via utilizing gene technology.
Current Investors
Hong Shan, CCB Private Equity Investment Management, Wuxi AppTec Group
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.